Office of the Director, National Institutes of Health; Notice of Closed Meeting, 7848 [2022-02824]
Download as PDF
<![CDATA[
7848
Federal Register / Vol. 87, No. 28 / Thursday, February 10, 2022 / Notices
website: https://heal.nih.gov/news where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
jspears on DSK121TN23PROD with NOTICES1
Notice is hereby given of a meeting of
the HEAL (Helping to End Addiction
Long-Term) Multi-Disciplinary Working
Group
The meeting will be open to the
public as indicated below via NIH
Videocast. Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The program documents
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the program
documents, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: HEAL MultiDisciplinary Working Group (MDWG)
Meeting.
Date: March 1–2, 2022.
Open: March 1, 2022, 11:00 a.m. to 12:30
p.m.
Closed: March 1, 2022, 12:30 p.m. to 4:30
p.m.
Closed: March 2, 2022, 11:00 a.m. to 4:30
p.m.
Agenda: To review and evaluate provide
an update on Helping to End Addiction
Long-Term (HEAL) Initiatives projects and
obtain expertise from MDWG relevant to the
NIH HEAL Initiative and to specific HEAL
projects.
Videocast: The open portion of the meeting
will be live webcast at: https://
videocast.nih.gov.
Place: National Institutes of Health,
Building 1, Wilson Hall, 1 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rebecca G Baker, Ph.D.,
Office of the Director, National Institutes of
Health, 1 Center Drive, Room 103A,
Bethesda, MD 20892, (301) 402–1994,
Rebecca.baker@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the Office
of the Director for the NIH HEAL Initiative
VerDate Sep<11>2014
18:18 Feb 09, 2022
Jkt 256001
Dated: February 4, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02824 Filed 2–9–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery National
Institute of Allergy and Infectious
Diseases (NIAID)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institute of Allergy and
Infectious Diseases (NIAID) will publish
periodic summaries of propose projects
to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Ms. Brandie Taylor,
Supervisory Program Analyst, Office of
Strategic Planning, Initiative
Development and Analysis, 5601
Fishers Lane, Rockville, Maryland
20892 or call non-toll-free number (240)
669–0296 or Email your request,
including your address to: taylorbr@
niaid.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NIAID), 0925–0668,
Expiration Date 4/30/2022,
EXTENSION, National Institute of
Allergy and Infectious Diseases (NIAID).
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
proposed information collection activity
provides a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the Administration’s
commitment to improving service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide information
about the NIAID’s customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
NIAID and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2511.
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 87, Number 28 (Thursday, February 10, 2022)]
[Notices]
[Page 7848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02824]
[[Page 7848]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Closed Meeting
Notice is hereby given of a meeting of the HEAL (Helping to End
Addiction Long-Term) Multi-Disciplinary Working Group
The meeting will be open to the public as indicated below via NIH
Videocast. Individuals who need special assistance, such as sign
language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The program documents and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the program documents, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: HEAL Multi-Disciplinary Working Group (MDWG)
Meeting.
Date: March 1-2, 2022.
Open: March 1, 2022, 11:00 a.m. to 12:30 p.m.
Closed: March 1, 2022, 12:30 p.m. to 4:30 p.m.
Closed: March 2, 2022, 11:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate provide an update on Helping to
End Addiction Long-Term (HEAL) Initiatives projects and obtain
expertise from MDWG relevant to the NIH HEAL Initiative and to
specific HEAL projects.
Videocast: The open portion of the meeting will be live webcast
at: https://videocast.nih.gov.
Place: National Institutes of Health, Building 1, Wilson Hall, 1
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rebecca G Baker, Ph.D., Office of the Director,
National Institutes of Health, 1 Center Drive, Room 103A, Bethesda,
MD 20892, (301) 402-1994, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Office of the Director for
the NIH HEAL Initiative website: https://heal.nih.gov/news where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: February 4, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02824 Filed 2-9-22; 8:45 am]
BILLING CODE 4140-01-P
